Policy & regulation

More details of a proposed $11 million-a-year ‘Neovascular AMD treatment incentive program’ that would financially encourage more ophthalmologists to bulk...

People living in the east of Perth’s vast metropolitan area have little or no access to public eyecare services, resulting...

Alexion, AstraZeneca rare disease treatment Ultomiris (ravulizumab rch) has become the first targeted treatment option to be reimbursed for people living...

Malaysia has banned the online sale of contact lenses and optical devices on e-commerce platforms. According to the New Straits Times...

Abolishment of non-compete clauses for employees, new investments in public hospitals and cheaper government-subsidised medicines are among the 2025/26 Federal...

Optometry Australia (OA) is intensifying its election campaign following what it calls “underwhelming responses” from key political parties, warning that...

Medical professionals working past the age of 70 are a small portion of the sector but apparently attract more than...

The Government’s Aged Care Act 2024 is a welcome commitment to the country’s older citizens, but a lack of clarity...

A nonprofit trade association for manufacturers and suppliers of the optical industry in the United States believes that trade tariffs kicked...

Optometry Australia says it is working with all private health funds towards standardisation, as practices continue to navigate a “minefield”...